JPS6148867B2 - - Google Patents
Info
- Publication number
- JPS6148867B2 JPS6148867B2 JP55102242A JP10224280A JPS6148867B2 JP S6148867 B2 JPS6148867 B2 JP S6148867B2 JP 55102242 A JP55102242 A JP 55102242A JP 10224280 A JP10224280 A JP 10224280A JP S6148867 B2 JPS6148867 B2 JP S6148867B2
- Authority
- JP
- Japan
- Prior art keywords
- hemoglobin
- weight
- liquid chromatography
- glucose
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000642 polymer Polymers 0.000 claims description 19
- 102000001554 Hemoglobins Human genes 0.000 claims description 17
- 108010054147 Hemoglobins Proteins 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 238000004811 liquid chromatography Methods 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000010557 suspension polymerization reaction Methods 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 6
- 239000007900 aqueous suspension Substances 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 4
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- JUDXBRVLWDGRBC-UHFFFAOYSA-N [2-(hydroxymethyl)-3-(2-methylprop-2-enoyloxy)-2-(2-methylprop-2-enoyloxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(CO)(COC(=O)C(C)=C)COC(=O)C(C)=C JUDXBRVLWDGRBC-UHFFFAOYSA-N 0.000 description 3
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N 1,2-diethylbenzene Chemical compound CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- INQDDHNZXOAFFD-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 2
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 description 2
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 2
- HLGNMOUJXWELKK-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)C(C)=C HLGNMOUJXWELKK-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- -1 acrylic ester Chemical class 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000011362 coarse particle Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- JDPZLHCKBWMLDH-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)C=C JDPZLHCKBWMLDH-UHFFFAOYSA-N 0.000 description 1
- LCKPEFUXKRSTMA-UHFFFAOYSA-N 6-propan-2-yl-7-oxabicyclo[4.1.0]hepta-2,4-diene Chemical compound C1=CC=CC2(C(C)C)C1O2 LCKPEFUXKRSTMA-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000007513 Hemoglobin A Human genes 0.000 description 1
- 108010085682 Hemoglobin A Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- BVVRPVFKRUVCJX-UHFFFAOYSA-N OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OCC(CO)CO Chemical compound OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.OCC(CO)CO BVVRPVFKRUVCJX-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
- FOVRCPBDDCLNIG-UHFFFAOYSA-N [3-(2-methylprop-2-enoyloxy)-2-(2-methylprop-2-enoyloxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(COC(=O)C(C)=C)COC(=O)C(C)=C FOVRCPBDDCLNIG-UHFFFAOYSA-N 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- LKFAPHHHWRMPGC-UHFFFAOYSA-N butan-1-ol prop-2-enoic acid Chemical compound CCCCO.OC(=O)C=C.OC(=O)C=C.OC(=O)C=C LKFAPHHHWRMPGC-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate group Chemical group C(C(=C)C)(=O)[O-] CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PGYIKLBGEVSGSN-UHFFFAOYSA-N phosphoric acid cyanide Chemical compound N#[C-].OP(O)(O)=O PGYIKLBGEVSGSN-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- ILLKMACMBHTSHP-UHFFFAOYSA-N tetradecaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ILLKMACMBHTSHP-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- ATCZPWFDFFKCPF-UHFFFAOYSA-K trisodium;acetic acid;phosphate Chemical compound [Na+].[Na+].[Na+].CC(O)=O.[O-]P([O-])([O-])=O ATCZPWFDFFKCPF-UHFFFAOYSA-K 0.000 description 1
- LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
【発明の詳細な説明】
本発明は試料中のとくに血液中のグルコーズ結
合ヘモグロビンの分離定量法に関するものであ
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for separating and quantifying glucose-bound hemoglobin in a sample, particularly in blood.
従来より糖尿病の診断法として血糖値(血液中
のグルコース濃度)測定が広く用いられている
が、血糖値は食事や運動の影響を直接受けるため
糖尿病の判定には数回にわたる検査が必要であ
る。糖尿病の治療指針には長期にわたる糖尿病の
コントロール状態を表現するものが必要である
が、この意味で血糖値は採血時の血糖を示すのみ
で不十分である。 Measuring blood sugar levels (glucose concentration in the blood) has traditionally been widely used as a diagnostic method for diabetes, but since blood sugar levels are directly affected by diet and exercise, multiple tests are required to determine diabetes. . Treatment guidelines for diabetes need to express the state of long-term diabetes control, but in this sense, it is insufficient to simply indicate the blood sugar level at the time of blood sampling.
近年、これらの問題を解消する新しい糖尿病の
診断法が開発された。すなわち赤血球中のヘモグ
ロビンが体内を循環している間に非酵素的に血液
中のグルコースと反応してグルコースヘモグロビ
ン(以下G−Hbと略す)となるが、このG−Hb
が長期間の血液中グルコースの時間平均的な濃度
を表現していることが判明し、このG−Hbの測
定による診断法が開発された。このG―Hbの測
定にはカチオン交換樹脂を用いる方法が提案され
ているが、この方法は他のカチオンの影響を受け
易い、再使用が困難である、G―Hbとヘモグロ
ビンAの分離が悪い等の欠点を有する。 In recent years, new diabetes diagnostic methods have been developed that solve these problems. In other words, while hemoglobin in red blood cells circulates in the body, it non-enzymatically reacts with glucose in the blood to form glucose hemoglobin (hereinafter abbreviated as G-Hb).
It was found that G-Hb expressed the time-averaged concentration of glucose in the blood over a long period of time, and a diagnostic method based on the measurement of G-Hb was developed. A method using a cation exchange resin has been proposed for measuring G-Hb, but this method is easily affected by other cations, is difficult to reuse, and has poor separation of G-Hb and hemoglobin A. It has the following disadvantages.
本発明はG―Hb測定における上記の如き現状
にかんがみ、よりすぐれた測定法を提供すること
を目的として鋭意研究せる結果なし得たものであ
り、その要旨は、
グルコーズ結合ヘモグロビンの検出が、一般
式;
(式中R1,R2は水素又はメチル基、nは3〜
18の整数である)で表わされる化合物100重量部
とxメチロールアルキルy(メタ)アクリレート
(式中x,yは整数であり、x≧y≧3である)
5〜60重量部よりなる混合物が、該混合物は溶解
するがその重合体は溶解しない有機溶媒の存在下
に水性懸濁重合されて得られた多孔性ポリマーよ
りなる液体クロマトグラフ用充填材が固定相とし
て用いられ、PH3.0〜9.0の水が溶離液とされる液
体クロマトグラフイーによつて行われることを特
徴とするグルコーズ結合ヘモグロビンの定量法に
存する。 The present invention was achieved as a result of intensive research aimed at providing a better measurement method in view of the above-mentioned current situation in G-Hb measurement. formula; (In the formula, R 1 and R 2 are hydrogen or methyl groups, and n is 3 to
100 parts by weight of a compound represented by x methylolalkyl y (meth)acrylate (where x and y are integers and x≧y≧3)
A liquid chromatography packing material made of a porous polymer obtained by aqueous suspension polymerization of a mixture consisting of 5 to 60 parts by weight in the presence of an organic solvent that dissolves the mixture but does not dissolve the polymer is fixed. A method for quantifying glucose-bound hemoglobin, characterized in that it is carried out by liquid chromatography in which water with a pH of 3.0 to 9.0 is used as a phase and as an eluent.
本発明で使用される一般式
で表わされる化合物は式中R1,R2は水素又はメ
チル基、nは3〜18の整数である、グリコールの
アクリル酸エステル若しくはメタクリル酸エステ
ルであつて、たとえばトリエチレングリコールジ
アクリレート、トリエチレングリコールジメタク
リレート、テトラエチレングリコールジアクリレ
ート、テトラエチレングリコールジメタクリレー
ト、ノナエチレングリコールジアクリレート、ノ
ナエチレングリコールジメタクリレート、テトラ
デカエチレングリコールジアクリレート、テトラ
デカエチレングリコールジメタクリレート等があ
げられる。 General formula used in the present invention The compound represented by the formula is an acrylic ester or methacrylic ester of glycol, in which R 1 and R 2 are hydrogen or a methyl group, and n is an integer of 3 to 18, such as triethylene glycol diacrylate, triethylene Examples include glycol dimethacrylate, tetraethylene glycol diacrylate, tetraethylene glycol dimethacrylate, nonaethylene glycol diacrylate, nonaethylene glycol dimethacrylate, tetradecaethylene glycol diacrylate, and tetradecaethylene glycol dimethacrylate.
上記一般式で表わされる化合物はnが1又は2
の際には疎水性が大であり親水性試料に適用でき
ず、又nが19より大になると粒子が軟らかくなり
高速液体クロマトグラフイ用充填材としては機械
的強度が不足するので、nは3〜18とされるので
あり好ましくは4〜14である。本発明で使用され
るxメチロールアルキルy(メタ)アクリレート
は式中x及びyは正の整数であつてx≧y≧3で
あり、その分子中に少くとも3個のメチロール基
と3個以上のアクリレート又はメタアクリレート
基を有する化合物であつてたとえばテトラメチロ
ールメタンテトラアクリレート、テトラメチロー
ルメタンテトラメタクリレート、テトラメチロー
ルメタントリアクリレート、テトラメチロールメ
タントリメタクリレート、トリメチロールメタン
トリアクリレート、トリメチロールメタントリメ
タクリレート、トリメチロールプロパントリアク
リレート、トリメチロールプロパントリメタクリ
レート等があげられ、テトラメチロールメタンテ
トラアクリレート、テトラメチロールメタントリ
アクリレート及びテトラメチロールメタントリメ
タクリレートなどが好適に使用される。そして前
記一般式で表わされる化合物と前記メチロールア
ルキルy(メタ)アクリレートとは混合物になさ
れるが、xメチロールアルキルy(メタ)アクリ
レートの添加量が少ないと得られた多孔性ポリマ
ーが軟らかく逆に多すぎると吸着、分配等の現象
が発生し分割能が低下するので、前記一般式で表
わされる化合物100重量部に対し5〜60重量部添
加されるのであり好ましくは10〜40重量部であ
る。 In the compound represented by the above general formula, n is 1 or 2
When n is too hydrophobic, it cannot be applied to hydrophilic samples, and when n is larger than 19, the particles become soft and lack mechanical strength as a packing material for high performance liquid chromatography. 3 to 18, preferably 4 to 14. The x methylol alkyl y (meth)acrylate used in the present invention has at least three methylol groups and three or more Compounds having an acrylate or methacrylate group, such as tetramethylolmethanetetraacrylate, tetramethylolmethanetetramethacrylate, tetramethylolmethane triacrylate, tetramethylolmethane trimethacrylate, trimethylolmethane triacrylate, trimethylolmethane trimethacrylate, Examples include methylolpropane triacrylate, trimethylolpropane trimethacrylate, and the like, and tetramethylolmethanetetraacrylate, tetramethylolmethane triacrylate, and tetramethylolmethane trimethacrylate are preferably used. The compound represented by the above general formula and the methylolakyl y (meth)acrylate are made into a mixture, but if the amount of x methylolakyl y (meth)acrylate added is small, the resulting porous polymer will be soft and porous. If too much, phenomena such as adsorption and distribution occur, resulting in a decrease in resolution. Therefore, 5 to 60 parts by weight, preferably 10 to 40 parts by weight, is added to 100 parts by weight of the compound represented by the above general formula.
本発明においては上記混合物は溶解するがその
重合体は溶解しない有機溶媒の存在下に水性懸濁
重合されるのであるが、上記有機溶媒としては上
記混合物を溶解するのがその重合体は溶解しない
すべての有機溶媒が使用可能であり、たとえばト
ルエン、キシレン、ジエチルベンゼン、ドデシル
ベンゼン等の芳香族炭化水素類、ヘキサン、ヘプ
タン、オクタン、デカン等の飽和炭化水素類、イ
ソアミルアルコール、ヘキシルアルコール、オク
チルアルコール等のアルコール類があげられ、そ
の添加量はなんら限定されるものではないが前記
混合物100重量部に対して15〜200重量部用いられ
るのが好ましく、より好ましくは20〜150重量部
である。なお有機溶媒は前記混合物に均一に溶解
されて、前記混合物が水性懸濁重合されるので得
られた重合体粒子中に分散して存在しており、重
合終了後上記有機溶媒を粒子中から取除くことに
より多孔性ポリマーが得られるのである。 In the present invention, aqueous suspension polymerization is carried out in the presence of an organic solvent that dissolves the mixture but does not dissolve the polymer.The organic solvent dissolves the mixture but does not dissolve the polymer. All organic solvents can be used, such as aromatic hydrocarbons such as toluene, xylene, diethylbenzene, dodecylbenzene, saturated hydrocarbons such as hexane, heptane, octane, decane, isoamyl alcohol, hexyl alcohol, octyl alcohol, etc. The amount of alcohol added is not limited in any way, but it is preferably used in an amount of 15 to 200 parts by weight, more preferably 20 to 150 parts by weight, per 100 parts by weight of the mixture. The organic solvent is uniformly dissolved in the mixture, and since the mixture is subjected to aqueous suspension polymerization, it exists dispersed in the resulting polymer particles, and after the polymerization is completed, the organic solvent is removed from the particles. By removing it, a porous polymer is obtained.
従つて前記混合体と相溶性の異なる種々の有機
溶媒を使用することにより多孔性ポリマーの細孔
の大きさを任意に変化させることができる。又水
性懸濁重合は公知の任意の方法が採用されればよ
く、たとえば前記有機溶媒に、前記混合物及びラ
ジカル発生触媒を溶解し、得られた溶液をポリビ
ニルアルコール、リン酸カルシウム等の懸濁重合
安定剤の分散された水相に添加し攪拌しながら50
〜100℃に加熱することにより行なわれる。 Therefore, by using various organic solvents having different compatibility with the above mixture, the pore size of the porous polymer can be arbitrarily changed. For the aqueous suspension polymerization, any known method may be used. For example, the mixture and the radical generating catalyst are dissolved in the organic solvent, and the resulting solution is mixed with a suspension polymerization stabilizer such as polyvinyl alcohol or calcium phosphate. Add to the dispersed aqueous phase with stirring for 50 min.
This is done by heating to ~100°C.
上記ラジカル発生触媒は反応開始剤としてラジ
カルを発生する触媒であるが、該触媒としてはた
とえばベンゾイルパーオキサイド、クメンバーオ
キサイド等の有機過酸化物、過酸化水素、過硫酸
カリウム、過硫酸アンモニウム等の無機過酸化
物、アゾビスイソブチロニトリル、アゾビスイソ
ブチロアミド等のアゾ化合物など公知の任意のラ
ジカル発生触媒が使用される。 The above radical generating catalyst is a catalyst that generates radicals as a reaction initiator. Examples of the catalyst include organic peroxides such as benzoyl peroxide and cumene oxide, and inorganic peroxides such as hydrogen peroxide, potassium persulfate, and ammonium persulfate. Any known radical generating catalyst can be used, such as peroxide, azo compounds such as azobisisobutyronitrile, and azobisisobutyramide.
上記水性懸濁重合によつて重合されたポリマー
粒子は加熱等により乾燥され粒子中の有機溶媒が
放出されることによつて多孔性ポリマーとなさ
れ、液体クロマトグラフ用充填材となされるので
ある。そして液体クロマトグラフ用充填材となさ
れるには多孔性ポリマーの粒子径は均一であり且
3〜40μmの範囲であるのが好ましい。 The polymer particles polymerized by the above-mentioned aqueous suspension polymerization are dried by heating or the like to release the organic solvent in the particles, thereby forming a porous polymer, which is used as a filler for liquid chromatography. In order to use the porous polymer as a packing material for liquid chromatography, it is preferable that the particle size of the porous polymer be uniform and within the range of 3 to 40 μm.
本発明においては上述の多孔性ポリマーが固定
相として液体クロマトグラフ用充填剤に用いられ
るのであるが、上記多孔性ポリマーを充填剤とし
て使用するには重合で得られた合成高分子粒子中
より微粒子および粗粒子を取り除いて得られた好
ましくは8〜12μ直径の粒子をイオン交換水に分
散し、ステンレスカラムに定流量ポンプによりイ
オン交換水で圧送して充填するのがよく、この様
にして得られたカラムを用いて液体クロマトグラ
フイの手法によりG―Hbの分離を行うのであ
る。 In the present invention, the above-mentioned porous polymer is used as a stationary phase in a packing material for liquid chromatography, but in order to use the above-mentioned porous polymer as a packing material, it is necessary to use finer particles among the synthetic polymer particles obtained by polymerization. Particles preferably having a diameter of 8 to 12μ obtained by removing coarse particles are preferably dispersed in ion-exchanged water, and the ion-exchanged water is pumped into a stainless column using a constant flow pump to fill the stainless steel column. G-Hb is separated using a liquid chromatography method using a column prepared by the company.
ヘモグロビンは周知のように64450の分子量を
有する蛋白質であり、人の正常なヘモグロビンは
α,β二種のサブチエイン2つづつの集合体より
なつている。このヘモグロビンにグルコーズが結
合することにより、G―Hbとなり、ヘモグロビ
ンの親水性が増加し、本発明における充填剤が用
いられた液体クロマトグラフイでは該G―Hbは
正常ヘモグロビンより短い時間で溶離されるので
あり、この様な理由で本発明においてG―Hbの
定量が可能となるのである。実際にクロマトグラ
フイーを行うにあたつては本発明における粒状合
成高分子からなる充填剤を固定相とし、溶離液と
しては、酢酸―酸ナトリウムあるいはリン酸―リ
ン酸ナトリウム系のような緩衝液を用い、PHが
3.0〜9.0好ましくは5.0〜9.0の範囲で溶離を行う
のである。又、PHを溶離途中で変化させたり、あ
るいは溶離速度を溶離途中で変化させることによ
り得られるクロマトグラム図形を改善することが
できる。 As is well known, hemoglobin is a protein with a molecular weight of 64,450, and normal human hemoglobin is composed of two aggregates of two subthieins, α and β. When glucose binds to hemoglobin, it becomes G-Hb, which increases the hydrophilicity of hemoglobin, and in liquid chromatography using the packing material of the present invention, G-Hb is eluted in a shorter time than normal hemoglobin. For this reason, it is possible to quantify G-Hb in the present invention. When actually performing chromatography, the packing material made of the granular synthetic polymer of the present invention is used as a stationary phase, and the eluent is a buffer such as acetic acid-sodium phosphate or phosphoric acid-sodium phosphate system. and the PH is
Elution is performed in the range of 3.0 to 9.0, preferably 5.0 to 9.0. Furthermore, the shape of the chromatogram obtained can be improved by changing the pH during elution or changing the elution rate during elution.
本発明のG―Hbの定量法は上述の通りの方法
であり、特に特定の多孔性ポリマーが固定相とし
て用いられるので、G―Hbを精度よくしかも簡
単に分離することが出来、さらに繰り返して使用
することも可能であるので、糖尿病の診断に有効
に用いられることが出来、臨床検査としての利用
価値の大きいものである。 The method for quantifying G-Hb of the present invention is as described above, and in particular, since a specific porous polymer is used as a stationary phase, G-Hb can be separated easily and accurately, and it can be repeated repeatedly. It can also be used effectively in the diagnosis of diabetes, and has great utility as a clinical test.
以下本発明の実施例について説明する。 Examples of the present invention will be described below.
実施例 1
冷却器、攪拌機、温度計および滴下ロートの設
置された2lセパラブルフラスコに4重量%のポリ
ビニルアルコール水溶液400mlとテトラエチレン
グリコールジメタクリレート90gとテトラメチロ
ールメタントリアクリレート10gおよびベンゾイ
ルパーオキサイド1.5gよりなる混合液を供給し
た。さらにトルエン100gを添加した。次に400r.
p.mに攪拌しながら80℃に昇温し、10時間反応を
行つて冷却した。冷却後、重合生成物を分離した
後熱水およびアセトンで洗浄して粒径が5〜20μ
mの多孔質球状ポリマーを得た。そのうち微粒子
および粗粒子を取り除いて得られた8〜12μmの
粒子を80mlのイオン交換水に分散し、ステンレス
カラム(直径7.9mm、長さ25cm)に定流量ポンプ
によりイオン交換水を1.6ml/minの速度で圧送
して充填した。得られた充填カラムを高速液体ク
ロマトグラフ(島津製作所製、LC2型)に接続し
た。次に上記高速液体クロマトグラフのカラムを
25℃に保つて以下の分離操作を行つた。正常人の
血液2mlを採血後、ヘバリン化し凝固を防ぎ、4
℃で遠心分離によつて血球血漿分離後、赤血球を
生理食塩水10mlで3回洗浄した。Example 1 In a 2L separable flask equipped with a condenser, stirrer, thermometer, and dropping funnel, 400ml of 4% by weight polyvinyl alcohol aqueous solution, 90g of tetraethylene glycol dimethacrylate, 10g of tetramethylolmethane triacrylate, and 1.5g of benzoyl peroxide are added. A mixed solution consisting of: Furthermore, 100 g of toluene was added. Next 400r.
The temperature was raised to 80°C while stirring at pm, the reaction was carried out for 10 hours, and the mixture was cooled. After cooling, the polymerization product is separated and washed with hot water and acetone to reduce the particle size to 5-20μ.
A porous spherical polymer of m was obtained. Particles of 8 to 12 μm obtained by removing fine particles and coarse particles were dispersed in 80 ml of ion-exchanged water, and ion-exchanged water was added at 1.6 ml/min to a stainless steel column (diameter 7.9 mm, length 25 cm) using a constant flow pump. It was filled by pressure feeding at a speed of . The obtained packed column was connected to a high performance liquid chromatograph (manufactured by Shimadzu Corporation, Model LC2). Next, attach the column of the high performance liquid chromatograph mentioned above.
The following separation operation was performed while maintaining the temperature at 25°C. After collecting 2 ml of blood from a normal person, it is converted into hevarin to prevent coagulation.
After blood cell plasma separation by centrifugation at °C, the red blood cells were washed three times with 10 ml of physiological saline.
次に洗浄赤血球に、1.5容の蒸留水および0.5容
のトルエンを加え、強く振とうして、溶血した。
これを4℃3000rpm、15分間の条件で遠心分離
し、溶血層の上澄を4℃でホスフエート―シアニ
ド緩衝液(Na2H2PO4・H2O4.59g/l、
Na2HPO41.19g/l KCN0.65g/l)にて24時
間透析(日本医理化プラスチツク製透析チユーブ
使用)した。この透析した溶血液を液体クマトグ
ラフ用検液とし、その1μlを注入した。 Next, 1.5 volumes of distilled water and 0.5 volumes of toluene were added to the washed red blood cells and shaken vigorously to cause hemolysis.
This was centrifuged at 4°C at 3000 rpm for 15 minutes, and the supernatant of the hemolyzed layer was cooled at 4 °C with phosphate-cyanide buffer ( Na2H2PO4.H2O4.59g /l,
Dialysis was performed for 24 hours (using a dialysis tube manufactured by Nippon Irika Plastics) against Na 2 HPO 4 1.19 g/l KCN 0.65 g/l). This dialyzed hemolysate was used as a liquid chromatograph test solution, and 1 μl of it was injected.
液体クロマトグラフの溶離液としては0.1Nり
ん酸緩衝液を用い最初PH6でクロマト開始し、正
常ヘモグロビンの大きなピークが現れる直前にPH
を7に切り換えて得られたクロマトグラムを第1
図に示す。本クロマトグラムは検出器として415
mmの波長の可視光を用いた。各ピークの帰属は修
酸によつてグリコーズをヘモグロビンから遊離さ
せしかる後、グリコーズオキシダーゼ法によりグ
リコーズの定量を行つて決定した。 0.1N phosphate buffer is used as the eluent for liquid chromatography, and the chromatography is started at pH 6, and the pH is increased just before the large peak of normal hemoglobin appears.
The chromatogram obtained by switching to 7 is the first
As shown in the figure. This chromatogram shows 415 as a detector.
Visible light with a wavelength of mm was used. The assignment of each peak was determined by liberating glycose from hemoglobin with oxalic acid and then quantifying glycose using the glycose oxidase method.
その結果ピーク2,3,4がグルコーズ結合ヘ
モグロビンであり、ピーク5が正常ヘモグロビン
であることが分つた。 As a result, it was found that peaks 2, 3, and 4 were glucose-bound hemoglobin, and peak 5 was normal hemoglobin.
ピーク2,3及び4の面積の合計と全面積(ピ
ーク1〜5の合計)との比は0.065であり、これ
は正常人のG―Hb量5〜8%の範囲内であつ
た。 The ratio of the sum of the areas of peaks 2, 3, and 4 to the total area (the sum of peaks 1 to 5) was 0.065, which was within the range of 5 to 8% of the G-Hb amount of a normal person.
実施例 2
使用したモノマーがノナエチレングリコールジ
メタクリレート80gとテトラメチロールメタント
リメタクリレート20gであること以外は実施例1
と同様な重合条件、分球操作で製造した多孔質球
状ポリマーを同様に充填操作し、実施例1と同じ
方法で処理した血液試料溶液を実施例1と同じ機
器及び緩衝液を用いてPH6.5で溶離を行つた。Example 2 Example 1 except that the monomers used were 80 g of nonaethylene glycol dimethacrylate and 20 g of tetramethylolmethane trimethacrylate.
A porous spherical polymer produced under the same polymerization conditions and sphere-splitting operation was similarly filled, and a blood sample solution treated in the same manner as in Example 1 was heated to pH 6 using the same equipment and buffer as in Example 1. Elution was performed at 5.
得られたクロマトグラムはピーク5がやゝ巾広
い以外は図1と同様のものであり、G―Hb量の
測定値は実施例1と殆んど同一であつた。 The obtained chromatogram was similar to FIG. 1 except that peak 5 was slightly broader, and the measured value of the G-Hb amount was almost the same as in Example 1.
第1図は実施例1において得られたクロマトグ
ラムを示す。
ピーク2,3,4…グルコーズ結合ヘモグロビ
ン、ピーク5…正常ヘモグロビン。
FIG. 1 shows the chromatogram obtained in Example 1. Peaks 2, 3, 4...Glucose-bound hemoglobin, Peak 5...Normal hemoglobin.
Claims (1)
式; (式中R1,R2は水素又はメチル基、nは3〜
18の整数である)で表わされる化合物100重量部
とxメチロールアルキルy(メタ)アクリレート
(式中x,yは整数であり、x≧y≧3である)
5〜60重量部よりなる混合物が、該混合物は溶解
するがその重合体は溶解しない有機溶媒の存在下
に水性懸濁重合されて得られた多孔性ポリマーよ
りなる液体クロマトグラフ用充填材が固定相とし
て用いられ、PH3.0〜9.0の水が溶離液とされる液
体クロマトグラフイーによつて行われることを特
徴とするグルコーズ結合ヘモグロビンの定量法。[Claims] 1. Detection of glucose-bound hemoglobin is performed using the general formula; (In the formula, R 1 and R 2 are hydrogen or methyl groups, and n is 3 to
100 parts by weight of a compound represented by x methylolalkyl y (meth)acrylate (where x and y are integers and x≧y≧3)
A liquid chromatography packing material made of a porous polymer obtained by aqueous suspension polymerization of a mixture consisting of 5 to 60 parts by weight in the presence of an organic solvent that dissolves the mixture but does not dissolve the polymer is fixed. A method for quantifying glucose-bound hemoglobin, characterized in that it is carried out by liquid chromatography, in which water with a pH of 3.0 to 9.0 is used as a phase and as an eluent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10224280A JPS5726746A (en) | 1980-07-24 | 1980-07-24 | Determining method of hemoglobin bound to glucose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10224280A JPS5726746A (en) | 1980-07-24 | 1980-07-24 | Determining method of hemoglobin bound to glucose |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5726746A JPS5726746A (en) | 1982-02-12 |
JPS6148867B2 true JPS6148867B2 (en) | 1986-10-27 |
Family
ID=14322146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10224280A Granted JPS5726746A (en) | 1980-07-24 | 1980-07-24 | Determining method of hemoglobin bound to glucose |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5726746A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0441937B1 (en) * | 1989-09-01 | 1993-10-20 | Mars Incorporated | Shelf-stable rice products and processes for their production |
JPH03164155A (en) * | 1989-11-22 | 1991-07-16 | Aichi Pref Gov | Sterilization of food or packaging material with alternate or mixed treatment using ozone and alcohol or organic acid |
-
1980
- 1980-07-24 JP JP10224280A patent/JPS5726746A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5726746A (en) | 1982-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4202775A (en) | Adsorbent for adsorbing organic compounds adsorbed on proteins | |
EP0163146B1 (en) | Separation method, separation device and separation apparatus for separating body fluid into respective components | |
EP0063947B1 (en) | Filler for liquid chromatography | |
JPS603367B2 (en) | Leukocyte separation method and leukocyte separation material | |
JPH021747A (en) | Macro-porous polymer film and its preparation | |
CN109266531A (en) | A kind of peripheral blood mononuclear cells separating pipe and preparation method thereof | |
CN102212177A (en) | Porous resin with surface hydrophily | |
JPS6148867B2 (en) | ||
JPH0373848A (en) | Packing material for liquid chromatography and production thereof | |
US5292818A (en) | Method for producing a carrier for cation exchange liquid chromatography and a method for determining glycosylated hemoglobins using the carrier | |
Källskoo et al. | Single glomerular blood flow as measured with carbonized 141‐Ce labelled microspheres | |
CN103230784A (en) | Composite continuous bed cryogel and preparation thereof, and application in separating IgG and albumin | |
JPH03255360A (en) | Separation and determination of glycohemoglobin | |
JP4758529B2 (en) | Packing agent for liquid chromatography and measuring method using the same | |
JPS5829134B2 (en) | Adsorption separation agent for blood purification | |
Yamaguchi et al. | Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma | |
JP4268730B2 (en) | Method for producing packing material for liquid chromatography | |
JPS58120607A (en) | Carrier having protein adsorbing function and its preparation | |
JPH0115024B2 (en) | ||
JPS6359463B2 (en) | ||
JP2004083561A (en) | Ion-exchanger for lipoprotein separation, and method for separating lipoprotein using the same | |
JP4037537B2 (en) | Packing for liquid chromatography | |
JPS58221164A (en) | Filler used for liquid chromatography | |
Marcus et al. | A New Immunoadsorbent for Hemoperfusion: Agarose-Polyacrolein Microspheres Beads I. In Vitro Studies | |
JP2960500B2 (en) | Fatty acid adsorbent |